456 related articles for article (PubMed ID: 25623820)
1. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Evaluation of Radiotherapy with Contrast-Enhanced Ultrasound in Non-Resectable Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.
Li H; Liu J; Chen M; Li H; Long L
Med Sci Monit; 2018 Nov; 24():8183-8189. PubMed ID: 30426970
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
[TBL] [Abstract][Full Text] [Related]
6. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
[TBL] [Abstract][Full Text] [Related]
7. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus.
Araki K; Harimoto N; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Tsushima Y; Shirabe K
Surg Today; 2020 Nov; 50(11):1496-1506. PubMed ID: 32613270
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization.
Pei XQ; Liu LZ; Zheng W; Cai MY; Han F; He JH; Li AH; Chen MS
Eur J Radiol; 2012 Mar; 81(3):e182-8. PubMed ID: 21349669
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
Lee JW; Hwang SH; Kim DY; Han KH; Yun M
Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
[TBL] [Abstract][Full Text] [Related]
11. Preliminary experience of a new perspective view technology for the detection of portal vein thrombus in hepatocellular carcinoma patients.
Wang W; Liu GJ; Chen LD; Wang Z; Zhou LY; Lu MD; Xie XY; Huang Y; Li W
Abdom Imaging; 2014 Dec; 39(6):1145-52. PubMed ID: 24760324
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
Chen J; Zhu J; Zhang C; Song Y; Huang P
Eur Radiol; 2020 May; 30(5):2871-2880. PubMed ID: 32020403
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided fine needle aspiration biopsy in differential diagnosis of portal vein tumor thrombosis.
Yang L; Lin LW; Lin XY; Gao SD; He YM; Yang FD; Xue ES; Lin XD
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):234-8. PubMed ID: 15908321
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
Kwon JH; Yoo SH; Nam SW; Lee YJ; Shin YR
Anticancer Res; 2020 Aug; 40(8):4351-4363. PubMed ID: 32727763
[TBL] [Abstract][Full Text] [Related]
18. The value of contrast enhanced ultrasound in the evaluation of the nature of portal vein thrombosis.
Dănilă M; Sporea I; Popescu A; Sirli R; Sendroiu M
Med Ultrason; 2011 Jun; 13(2):102-7. PubMed ID: 21655535
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
20. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
